ConductScience.org, home

Gene · 7436

VLDLR: very low density lipoprotein receptor

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. VLDLR: very low density lipoprotein receptor. Genes, record 7436. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/7436

On this page

Gene

Symbol
VLDLR
HGNC
Name
very low density lipoprotein receptor
HGNC
NCBI Gene ID
7436
NCBI Gene
HGNC ID
HGNC:12698
HGNC
Ensembl
ENSG00000147852
NCBI Gene
Aliases
CAMRQ1, CARMQ1, CHRMQ1, VLDL-R, VLDLRCH
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P98155Very low-density lipoprotein receptor87327Ensembl, GeneID, HGNC

Source UniProt

Patents70

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026067851 A2026-04-21389P98155Espacenet
JP 2026004568 A2026-01-1469635P98155Espacenet
EP 4650780 A22025-11-1910519P98155Espacenet
EP 4641201 A22025-10-2910873P98155Espacenet
JP 2025147176 A2025-10-0614082P98155Espacenet
JP 2025529142 A2025-09-045231P98155Espacenet
JP 2025529142 A2025-09-048031P98155Espacenet
US 12371689 B22025-07-295231P98155Espacenet
US 12371689 B22025-07-298031P98155Espacenet
JP 2025517969 A2025-06-1210873P98155Espacenet

1 to 10 of 70

See all 70 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,740

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleVLDLR papersNewest fiscal year
R01EY019309A new pathogenic mechanism for diabetic retinopathy122025
R01AI164653LDLRAD3 Receptor Interaction with Venezuelan Equine Encephalitis Virus102025
R01EY017017Dietary control of angiogenesis in retinopathy models72025
R01HL056051Fibrin(ogen) Structure and Interactions72025
P30CA021765Cancer Center Support Grant (CCSG)62025
R01AI143673Structure-Function Analysis of Mxra8 Interaction with Alphaviruses62025
R01NS058721ACC: Callosal Agenesis as a Window into Common Neurodevelopmental Disorders62025
R01EY024963RORalpha mediates chronic subretinal inflammation associated with AMD52025
R01NS017950Precursors of Stroke Incidence and Prognosis52025
P30DK056341Washington University Nutrition Obesity Research Center42025

1 to 10 of 1,740Source NIH's project files

See all 1,740 nih grants

Papers2,532

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
APOC1-Associated VLDL-Pathway Dysregulation in Papillary Thyroid Carcinoma: A Reproducible Cross-Cohort Transcriptomic Signature Associated With the Diagnostic-to-Treatment Interval.Chem Biol Drug Des202642742374PubTator, text miningPubMed
Sustained estimated VLDL-C exposure is associated with cardiometabolic multimorbidity and foam cell dysfunction: evidence from prospective cohorts and in vitro studies.J Geriatr Cardiol202642741040PubTator, text miningPubMed
Jer1-Ga2-LpR1 axis mediates upstream input of alpha-mannosidosis.J Mol Cell Biol202642667363PubTator, text miningPubMed
Identification and validation of mitophagy and astrocyte-related molecular signature in the pathogenesis of Alzheimer's disease: evidence from ensemble learning-driven multi-omics and clinical validation.
Front Neurosci202642568632PubTator, text miningPubMed
Interferon-elicited lipoprotein metabolism in lung fibroblasts facilitates premetastatic niche formation.Nat Commun202642386744PubTator, text miningPubMed
Apolipoprotein E in Alzheimer's disease: A review of APOE receptors, signalling pathways and therapeutic opportunities.Mol Cell Neurosci202642362005PubTator, text miningPubMed
LRP4 is an entry receptor for multiple encephalitic alphaviruses.Nat Commun202642265108PubTator, text miningPubMed
The association study of genetic variants with developing musical aptitude in humans.Vavilovskii Zhurnal Genet Selektsii202642245177PubTator, text miningPubMed
Lipoprotein receptors in hepatitis C virus entry - a structural view.Curr Opin Virol202642119247PubTator, text miningPubMed
Identification of a Novel VLDLR Variant in the First Report of CAMRQ1 From Africa: Expanding the Spectrum of Cerebellar Ataxia Syndromes.Hum Mutat202642051465PubTator, text miningPubMed

1 to 10 of 2,532

See all 2,532 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/7436

GET https://conductscience.org/api/genes/v1/7436/patents?page=2